US FDA declines to approve AbbVie’s wrinkle treatment due to manufacturing concerns (April 23)

Investing.com Gold reports: US FDA declines to approve AbbVie’s wrinkle treatment due to manufacturing concerns (April 23). Full body text was unavailable at ingest time, so this brief is based on headline context.